Verasonics announces international patent grants for advanced ultrasound transceiver technology
08/10/2026
Verasonics Inc, a leader in research ultrasound, has announced patent grants in Canada, China, Israel, Japan and Korea for its ultrasonic transceiver architecture, with a related application pending in Europe. The company also announced a new USA provisional application for several novel applications using its active clamp technology.
The newly granted patents extend patent protection beyond its previously granted US Patent No 12089991, ‘Ultrasound Transmitter with Low Distortion and Concurrent Receive’. The patented architecture is used on the Vantage NXT platform and supports high-power, high-frequency arbitrary waveforms with low distortion while enabling transmit-signal monitoring through the receive path during transmission.
The provisional patent application builds on this architecture with the use of active clamp circuits in the transceiver to protect sensitive receiver electronics while extracting meaningful measurement data during high-voltage transmit events.
“These developments reflect our continued investment in innovative ultrasound technologies,” said Jon K Daigle, CEO of Verasonics. “Our growing intellectual property portfolio helps protect the technologies that differentiate our platforms and enable new breakthroughs in research for commercialisation.”
Together, the granted and pending filings expand Verasonics’ broad portfolio of ultrasound patent assets and align with the company’s core mission to provide high-performance ultrasound platforms. These platforms help researchers, engineers and commercial partners rapidly prototype, validate and commercialise new techniques across biomedical imaging, focused ultrasound, photoacoustics, non-destructive testing and other emerging applications.
verasonics.com
